BLOG/🇺🇸United States··daily

All NASA Contracts — January 08, 2026

All NASA Contracts

6 total filings analysed

Executive Summary

NASA obligated $1.27B across 6 contracts in this period, with 95%+ concentrated on Caltech (nonprofit JPL manager) for long-term space R&D projects through 2028, yielding neutral equity signals due to limited public market exposure. The standout bullish award to KBR Wyle Services ($53.5M obligated, $1.29B base+options) signals competed growth in NASA JSC medical R&D starting 2025. Overall, stable multi-year funding underscores sector resilience but highlights execution risks from unexercised options and delivery order dependencies.

Tracking the trend? Catch up on the prior All NASA Contracts digest from January 07, 2026.

Investment Signals(2)

  • KBR Wyle secures $1.29B NASA medical R&D ceiling(HIGH)

    Competed cost-plus award fee delivery order at JSC with $53.5M initial obligation offers massive upside as $0 outlayed with 2025 start.

  • Caltech dominates JPL space R&D funding(HIGH)

    Five awards totaling ~$1.21B obligated (up to $1.54B with options) for NEO Surveyor, exoplanets, Earth science through 2028 provide stable nonprofit funding.

Risk Flags(2)

  • Execution[MEDIUM RISK]

    Long performance periods to 2028 expose Caltech projects to funding shifts, delays, or mission changes; delivery orders depend on parent task fulfillment.

  • Execution[HIGH RISK]

    KBR Wyle's $53.5M obligation vs. $1.29B ceiling with $0 outlayed and 2025 start risks non-exercise amid 1-year term.

Opportunities(2)

  • $1.46B+ in unexercised options across contracts, led by KBR's $1.24B gap.

  • Sustained JPL funding for NEO, exoplanet, Earth science R&D signals multi-year space science pipeline.

Sector Themes(2)

  • Caltech captures 95%+ of obligations via non-competed JPL delivery orders for applied R&D (NAICS 541715, PSC AR22).

  • Competed KBR award (PSC Q999) highlights shift to human spaceflight support with $1.29B ceiling.

Watch List(3)

  • 👁

    {"entity"=>"KBR Wyle Services", "reason"=>"$1.29B potential dwarfs current $53.5M obligation in competed medical R&D.", "trigger"=>"Option exercises or outlays >$100M in 2025"}

  • 👁

    {"entity"=>"Caltech NEO Surveyor", "reason"=>"Largest single award ($722M obligated, $922M potential) with $611M outlayed.", "trigger"=>"2027 completion delays or full option funding"}

  • 👁

    {"entity"=>"NASA JPL Delivery Orders", "reason"=>"Cluster of 5 long-term awards signals funding continuity risks.", "trigger"=>"Budget cuts or task order slowdowns"}

Get daily alerts with 2 investment signals, 2 risk alerts, 2 opportunities and full AI analysis of all 6 filings

🇺🇸 More from United States

View all →